142 related articles for article (PubMed ID: 19189299)
1. Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer.
Hong SK; Lee ST; Kim SS; Min KE; Byun SS; Cho SY; Choe G; Lee SE
Prostate; 2009 Jun; 69(8):820-6. PubMed ID: 19189299
[TBL] [Abstract][Full Text] [Related]
2. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
Egan AJ; Bostwick DG
Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
[TBL] [Abstract][Full Text] [Related]
3. Glycemic control and prostate cancer progression: results from the SEARCH database.
Kim HS; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ
Prostate; 2010 Oct; 70(14):1540-6. PubMed ID: 20687228
[TBL] [Abstract][Full Text] [Related]
4. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus is associated with short prostate-specific antigen doubling time after radical prostatectomy.
Oh JJ; Hong SK; Lee S; Sohn SJ; Lee SE
Int Urol Nephrol; 2013 Feb; 45(1):121-7. PubMed ID: 23054323
[TBL] [Abstract][Full Text] [Related]
6. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer.
Narayan P; Gajendran V; Taylor SP; Tewari A; Presti JC; Leidich R; Lo R; Palmer K; Shinohara K; Spaulding JT
Urology; 1995 Aug; 46(2):205-12. PubMed ID: 7542823
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum sex hormone-binding globulin as a predictive marker for extraprostatic extension of tumor in patients with clinically localized prostate cancer.
Lee SE; Chung JS; Han BK; Park CS; Moon KH; Byun SS; Choe G; Hong SK
Eur Urol; 2008 Dec; 54(6):1324-32. PubMed ID: 18339472
[TBL] [Abstract][Full Text] [Related]
8. Preoperative glycemic control status as a significant predictor of biochemical recurrence in prostate cancer patients after radical prostatectomy.
Lee H; Kuk H; Byun SS; Lee SE; Hong SK
PLoS One; 2015; 10(4):e0124761. PubMed ID: 25897669
[TBL] [Abstract][Full Text] [Related]
9. [Preoperative parameters, including percent of positive biopsy cores, in predicting pathological findings after radical prostatectomy].
Inagaki T; Kohjimoto Y; Hagino K; Kuramoto T; Mori T; Kikkawa K; Iba A; Uekado Y; Shinka T
Nihon Hinyokika Gakkai Zasshi; 2007 Mar; 98(3):565-72. PubMed ID: 17419367
[TBL] [Abstract][Full Text] [Related]
10. Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy.
Jackson W; Hamstra DA; Johnson S; Zhou J; Foster B; Foster C; Li D; Song Y; Palapattu GS; Kunju LP; Mehra R; Feng FY
Cancer; 2013 Sep; 119(18):3287-94. PubMed ID: 23821578
[TBL] [Abstract][Full Text] [Related]
11. Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer.
Hegde JV; Veruttipong D; Said JW; Reiter RE; Steinberg ML; King CR; Kishan AU
Urology; 2017 Sep; 107():171-177. PubMed ID: 28552819
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
[TBL] [Abstract][Full Text] [Related]
13. A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Schnall M; Tomaszewski J; Schultz D; Kao G; VanArsdalen K; Wein A
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):293-302. PubMed ID: 7928457
[TBL] [Abstract][Full Text] [Related]
14. Indications for preoperative seminal vesicle biopsies in staging of clinically localized prostatic cancer.
Guillonneau B; Debras B; Veillon B; Bougaran J; Chambon E; Vallancien G
Eur Urol; 1997; 32(2):160-5. PubMed ID: 9286646
[TBL] [Abstract][Full Text] [Related]
15. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
Gao X; Mohideen N; Flanigan RC; Waters WB; Wojcik EM; Leman CR
J Urol; 2000 Dec; 164(6):1982-6. PubMed ID: 11061896
[TBL] [Abstract][Full Text] [Related]
16. Poor glycemic control of diabetes mellitus is associated with higher risk of prostate cancer detection in a biopsy population.
Park J; Cho SY; Lee YJ; Lee SB; Son H; Jeong H
PLoS One; 2014; 9(9):e104789. PubMed ID: 25198675
[TBL] [Abstract][Full Text] [Related]
17. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
[TBL] [Abstract][Full Text] [Related]
18. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
20. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]